Advertisement · 728 × 90
#
Hashtag
#Drugsdevelopment
Advertisement · 728 × 90
Preview
Unmet needs in vaccine development Discover the world’s best science and medicine | Nature.com

#Medsky🧪 #IDsky #drugsdevelopment #immunosky #publichealth Mortality, prevalence , burden of #infectiousdiseases & Unmet needs in #vaccine development @natrevdrugdiscov.nature.com

www.nature.com/articles/d41...

6 6 0 0

#Medsky #oncosky #Drugsdevelopment #publichealthThe hormone erythropoietin is best known as a performance-enhancing drug & is banned from professional and college sports for its ability to boost endurance. But cheating athletes aren’t the only dubious characters using it to gain an advantage and

2 0 1 0
Preview
Complex Innovative Trial Design Meeting Program Complex Innovative Designs

#Medsky🧪 #Drugdelivery #drugsdevelopment #academisky Complex Innovative Trial Design Meeting Program update

www.fda.gov/drugs/develo...

3 0 0 0
Preview
MMTV RNA packaging requires an extended long-range interaction for productive Gag binding to packaging signals The role of long-range interactions (LRI) in retroviral RNA packaging is unclear. This study found that a specific packaging signal (Psi) structure, maintained by an extended LRI, is crucial for effic...

#MedSky🧪#IDSky #ImmunoSky #Drugsdevelopment Understanding Retroviral Life Cycle and its Genomic RNA Packaging

journals.plos.org/plosbiology/...

0 0 0 0
Azvudine

Azvudine

#MedSky🧪 #IDSky #Publichealth #Immunopharmacology #Clinical_ID #Drugsdevelopment Summary #Antivirals for #COVID19 Therapeutic Options Alt #Paxlovid
x.com/castltraston...

1 1 0 0
Preview
C-type lectin-like receptor 2: roles and drug target - Thrombosis Journal C-type lectin-like receptor-2 (CLEC-2) is a member of the C-type lectin superfamily of cell surface receptors. The first confirmed endogenous and exogenous ligands of CLEC-2 are podoplanin and rhodocy...

#Immunopharmacology #Drugsdiscovery Brief introduction of C-type lectin-like receptor 2: Roles & #drugsdevelopment that targeting #COVID19 , #Tumour , #DVT & the other diseases related #thrombosis thrombosisjournal.biomedcentral.com/articles/10....

0 0 0 0

MedSky🧪 #IDSky #Viralimmunology #Clinical_ID #Drugsdevelopment perspectives #publichealth @aaas Where do we go wrong ? Pfizer’s antiviral #Paxlovid may not help as many people as hoped. The combo drug was granted emergency use authorization in 2021 in 🇺🇸

2 1 1 0
Preview
Clinical development of antivirals against SARS-CoV-2 and its variants The unceasing global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calls for the development of novel therapeutics. Although …

MedSky🧪 #IDSky #Drugsdiscovery #Drugsdevelopment #Immunopharmacology Summarize the latest advancements in the #clinicaldevelopment of #antivirals against infections by #SARSCoV2 and its variants.

www.sciencedirect.com/science/arti...

4 2 0 0
Path ways

Path ways

MedSky🧪#Cancerbiology #Drugsdiscovery #Drugsdevelopment Understanding of targetable protein lipidation pathways in Cancer & mechanisms, dysregulation and emerging drug targets
www.nature.com/articles/s41...

0 0 0 0
Preview
Harnessing natural killer cell effector function against cancer Summary. Natural killer (NK) cells are cytotoxic innate lymphoid cells that participate in anti-tumour and anti-viral immune responses. Their ability to rapidly

MedSky🧪#Drugsdelivery #Drugsdevelopment #Immunooncology Overview of NK-cell therapy & Advantages for targeting NK cells in cancer

academic.oup.com/immunotherap...

0 0 0 0
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 | NEJM Original Article from The New England Journal of Medicine — Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

MedSky🧪#IDSky #Drugsdevelopment #Clinicaltrial Evaluate the Efficacy and Safety of SIM0417 /Oral #Simnotrelvir Orally Co-Administered With #Ritonavir in Symptomatic Adult Participants With Mild to Moderate #COVID19

www.nejm.org/doi/10.1056/...

0 0 0 0
Highlight

Highlight

MedSky🧪#IDSky #Microbiology #Drugsdevelopment where are we with Clinical development of #antivirals against #SARSCoV2 & its variants ?

www.sciencedirect.com/science/arti...

1 0 0 0
Schematic representation of the IFN receptors network.

Schematic representation of the IFN receptors network.

#MedSky🧪 #IDSky #ImmunoSky #Viralimmunology #Drugsdevelopment Overview the role of #interferons in host immunity & Viral infection : from virus-host crosstalk to prophylactic and therapeutic potential in #SARSCoV2 infection.

2 0 1 0

MedSky🧪IDSky #Mucosalimmunity #COVID19 #Drugsdevelopment the studies show that how and where vaccines are delivered can have a profound effect on the immunity generated and the protection conferred.

0 0 1 0
RNA is in vitro transcribed with nucleoside bases that include N-1-methylpseudouridine, which substitutes for unmodified uridine. The synthesized mRNA is capped, purified, and encapsulated into a lipid nanoparticle (LNP), which includes an ionizable lipid. Upon intramuscular injection, the LNP enters the endosomes of cells, and the RNA is released into the cytoplasm where it is translated into protein. The inclusion of the N-1-methylpseudouridine, 5′ cap, sequence optimization, and purification reduce innate immune activation and translational inhibition. The LNP has adjuvant activity that includes induction of IL-1β and IL-6. Transfected cells translate the mRNA into protein, which is subsequently processed and loaded on major histocompatibility molecules and presented to T cells or presented on the cell surface for recognition by B cells. Figure created with BioRender.com, generated by A. Amabile (Mount Sinai).

RNA is in vitro transcribed with nucleoside bases that include N-1-methylpseudouridine, which substitutes for unmodified uridine. The synthesized mRNA is capped, purified, and encapsulated into a lipid nanoparticle (LNP), which includes an ionizable lipid. Upon intramuscular injection, the LNP enters the endosomes of cells, and the RNA is released into the cytoplasm where it is translated into protein. The inclusion of the N-1-methylpseudouridine, 5′ cap, sequence optimization, and purification reduce innate immune activation and translational inhibition. The LNP has adjuvant activity that includes induction of IL-1β and IL-6. Transfected cells translate the mRNA into protein, which is subsequently processed and loaded on major histocompatibility molecules and presented to T cells or presented on the cell surface for recognition by B cells. Figure created with BioRender.com, generated by A. Amabile (Mount Sinai).

MedSky🧪 #Drugsdelivery #Drugsdevelopment #IDsky RNA Vaccines .A step at the time in educating the immune system @ImmunityCP

www.cell.com/immunity/ful...

3 1 0 0

MedSky🧪 #Drugsdevelopment perspective .Safety failures are an important factor in low drug development success rates. Human genetic evidence can select drug targets causal in disease and enrich for successful programs.

1 0 0 0
Preview
HIV vaccine trial in Africa halted after disappointing initial results African-led trial ended a year early as researchers conclude there is ‘little or no chance’ new combination vaccines cut HIV risk

MedSky🧪#IDSky #Drugsdevelopment #HIVvaccine #clinicaltrial in Africa halted after disappointing initial results. African-led trial ended a year early as researchers conclude there is ‘little or no chance’ new combination vaccines cut #HIV risk

www.theguardian.com/global-devel...

1 1 0 0
Preview
The Next Generation of COVID-19 Vaccines May be Inhaled This Medical News story discusses experimental mucosal COVID-19 vaccines.

MedSky🧪IDSky #Drugsdiscovery #Drugsdevelopment Up the Nose and Down the Windpipe May Be the Path to New & Improved #COVID19Vaccines How these experimental #mucosalvaccines stack up against #mRNAvaccines and what’s in the pipeline ?

jamanetwork.com/journals/jam...

5 2 0 0
The life cycle of SARS-CoV-2 and targets for some antivirals. Entry-stage: SARS-CoV-2 particles use their Spike (S) protein to interact with receptor molecules (human ACE2) for viral entry. During the viral entry process, monoclonal antibodies can inhibit the interaction of S protein and ACE2 protein to inhibit viral entry, while TMPRSS-2 inhibitors and Cathepsin B/L inhibitors can inhibit proteolytic activation of spike protein to inhibit viral entry. Peptide inhibitors targeting HR1 (EK1 and HR2P) can inhibit 6-HB formation to block viral entry. Post-entry stage: Viral protein cleavage and RNA synthesis are important processes for the SARS-CoV-2 replication cycle. Mpro and PLpro are important proteases responsible for viral protein cleavage, and these processes can be halted by protease inhibitors, including, for example, nirmatrelvir (PF-07321332) and ensitrelvir. RdRp is important for viral RNA synthesis, and these processes can be stopped by RdRp inhibitors, such as remdesivir, VV

The life cycle of SARS-CoV-2 and targets for some antivirals. Entry-stage: SARS-CoV-2 particles use their Spike (S) protein to interact with receptor molecules (human ACE2) for viral entry. During the viral entry process, monoclonal antibodies can inhibit the interaction of S protein and ACE2 protein to inhibit viral entry, while TMPRSS-2 inhibitors and Cathepsin B/L inhibitors can inhibit proteolytic activation of spike protein to inhibit viral entry. Peptide inhibitors targeting HR1 (EK1 and HR2P) can inhibit 6-HB formation to block viral entry. Post-entry stage: Viral protein cleavage and RNA synthesis are important processes for the SARS-CoV-2 replication cycle. Mpro and PLpro are important proteases responsible for viral protein cleavage, and these processes can be halted by protease inhibitors, including, for example, nirmatrelvir (PF-07321332) and ensitrelvir. RdRp is important for viral RNA synthesis, and these processes can be stopped by RdRp inhibitors, such as remdesivir, VV

MedSky🧪IDSky #immunoSky #Drugsdevelopment #Drugsdiscovery Overview & Summaries of the clinical development of #antivirals targeting various factors to inhibit #SARSCoV2 infection, including both viral factors & host factors.

3 0 1 0
Preview
Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials An investigational messenger RNA (mRNA)–based vaccine designed to protect against both influenza and COVID-19 induced virus-specific immune responses in people

MedSky🧪 IDSky #PublicHealth #ClinicalTrial #Drugsdevelopment
An investigational messenger RNA (mRNA)–based vaccine designed to protect against both influenza & #COVID19 induced virus-specific #immuneresponses in people who received it
jamanetwork.com/journals/jam...

8 2 1 1